Human mitochondria maintain a small circular DNA that encodes several subunits of the proteins involved in oxidative phosphorylation as well as ribosomal and transport RNA. Defects in mtDNA expression result in a number of myopathies such as MELAS (mitochondrial encephalomyopath, lactic acidosis, and stroke-like syndrome), MERRF (myoclonic epilepsy with ragged red fibers syndrome), hearing and vision loss, and others. Moreover, mitochondria are implicated in age-related pathology, senescence and cancer and thus represent a rational but understudied therapeutic target. The key enzyme involved in mtDNA expression, mitochondrial RNA polymerase (mtRNAP) belongs to a family of single-subunit RNAPs that is distinct from the multi-subunit cellular RNAPs but distantly related to RNAPs of bacteriophage T7, the pol I familty of DNA polymerases, and single-subunit RNAPs from chloroplasts. However, unlike T7 RNAP, human mtRNAP requires two transcription factors, TFAM and TFB2M for efficient initiation, and its transcription appears to be regulated by a number of transcription factors. Studies of the structure and function of the mtRNAP and molecular mechanisms of its transcription are important for understanding the regulation of mitochondrial genome expression. This, in turn, will determine our ability to influence various mitochondrial functions and as a consequence, to treat mitochondria-associated diseases. The goal of this project is to determine the molecular mechanisms of transcription initiation by human mtRNAP.
The specific aims are as follows:
Aim 1. Determine the molecular basis of transcription initiation by mtRNAP. The high resolution structure of mtRNAP will be used to guide biochemical experiments to probe the function of mtRNAP domains that are involved in promoter binding, recognition, melting and interactions with transcription factors. Transitions of mtRNAP during initiation to elongation will be probed by cross-linking and by structural analysis of the mtRNAP elongation complex.
Aim 2. Determine function and structure of the pre-initiation complex. Using protein-protein cross-linking we will determine the organization of a novel transcription intermediate - pre-initiation complex formed with TFAM and mtRNAP on promoter DNA. Interacting regions in both TFAM and mtRNAP will be mapped and their functional importance probed by mutagenesis. The structure of the pre-initiation complex will be determined at the atomic resolution and its function probed in various biochemical assays.
Aim 3. Determine function and structure of the open promoter complex. Protein-protein cross-linking using artificial photo reactive amino acid will be used to test the model of TFB2M interaction with mtRNAP during initiation and to probe assembly of the initiation complex. The role of TFB2M in transcription start site selection, promoter specificity and promoter melting will be examined. The crystal structure of the core initiation complex that includes mtRNAP, TFAM, TFB2M and promoter DNA will be determined.

Public Health Relevance

Defects in mitochondrial gene expression are associated with a number of complex, degenerative disorders and aging. Studies of mitochondrial transcription and its regulation can be used to identify mechanisms or substances that impair or stimulate gene expression. This knowledge will help development of the treatments of human diseases that result from aberrant RNAP activity as well as development of novel therapeutic agents that target mitochondria of eukaryotic parasites.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Molecular Genetics A Study Section (MGA)
Program Officer
Sledjeski, Darren D
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rowan University School/Osteopathic Med
United States
Zip Code
Hillen, Hauke S; Parshin, Andrey V; Agaronyan, Karen et al. (2017) Mechanism of Transcription Anti-termination in Human Mitochondria. Cell 171:1082-1093.e13
Morozov, Yaroslav I; Temiakov, Dmitry (2016) Human Mitochondrial Transcription Initiation Complexes Have Similar Topology on the Light and Heavy Strand Promoters. J Biol Chem 291:13432-5
Morozov, Yaroslav I; Parshin, Andrey V; Agaronyan, Karen et al. (2015) A model for transcription initiation in human mitochondria. Nucleic Acids Res 43:3726-35
Agaronyan, Karen; Morozov, Yaroslav I; Anikin, Michael et al. (2015) Mitochondrial biology. Replication-transcription switch in human mitochondria. Science 347:548-51
Morozov, Yaroslav I; Agaronyan, Karen; Cheung, Alan C M et al. (2014) A novel intermediate in transcription initiation by human mitochondrial RNA polymerase. Nucleic Acids Res 42:3884-93
Lu, Bin; Lee, Jae; Nie, Xiaobo et al. (2013) Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. Mol Cell 49:121-32
Schwinghammer, Kathrin; Cheung, Alan C M; Morozov, Yaroslav I et al. (2013) Structure of human mitochondrial RNA polymerase elongation complex. Nat Struct Mol Biol 20:1298-303